---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-290309"
form_type: "8-K"
ticker: "TCRX"
cik: "0001783328"
company_name: "TScan Therapeutics, Inc."
filed_at: "2023-12-07T23:59:59+00:00"
generated_at: "2026-06-07T16:20:17.620171+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# TScan Therapeutics appoints R. Keith Woods to Board of Directors, effective immediately

## Summary
- Woods appointed as Class II director, serving on Audit and Compensation Committees.
- Over 30 years life science experience; most recently COO of argenx, leading commercialization.
- Received option to purchase 17,500 shares of TCRX common stock, vesting over one year or until 2024 annual meeting.
- Board committees: Audit (Woods, Dorton, Gruia, Klencke); Compensation (Woods, Biggar, Dorton, Klencke).

## SEC filing metadata
- accession: 0001193125-23-290309
- form_type: 8-K
- ticker: TCRX
- cik: 0001783328
- company_name: TScan Therapeutics, Inc.
- filed_at: 2023-12-07T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1783328/000119312523290309/0001193125-23-290309-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1783328/000119312523290309/d891696d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-290309
- JSON: https://secwatch.observer/filing/0001193125-23-290309.json
- Plain text: https://secwatch.observer/filing/0001193125-23-290309.txt

## Key facts
- Executive change
  R. Keith Woods was appointed as Class II director at TScan Therapeutics, Inc..
  - Action: appointed
  - Role: Class II director
  source text: On December 6, 2023, the Board of Directors (the “Board”) of TScan Therapeutics, Inc. (the “Company”) appointed R. Keith Woods, to the Board, effective December 6, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1783328/000119312523290309/0001193125-23-290309-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.